Cargando…
Transient Responses to NOTCH and TLX1/HOX11 Inhibition in T-Cell Acute Lymphoblastic Leukemia/Lymphoma
To improve the treatment strategies of T-cell acute lymphoblastic leukemia/lymphoma (T-ALL), further efforts are needed to identify therapeutic targets. Dysregulated expression of HOX-type transcription factors occurs in 30–40% of cases of T-ALL. TLX1/HOX11 is the prototypical HOX-type transcription...
Autores principales: | Rakowski, Lesley A., Lehotzky, Erica A., Chiang, Mark Y. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033898/ https://www.ncbi.nlm.nih.gov/pubmed/21326611 http://dx.doi.org/10.1371/journal.pone.0016761 |
Ejemplares similares
-
TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells
por: Riz, Irene, et al.
Publicado: (2010) -
Phosphorylation of HOX11/TLX1 on Threonine-247 during mitosis modulates expression of cyclin B1
por: Chen, Edwin, et al.
Publicado: (2010) -
Transcriptional regulation of the human ALDH1A1 promoter by the oncogenic homeoprotein TLX1/HOX11
por: Rice, Kim L., et al.
Publicado: (2009) -
Association of TLX1 gene polymorphisms with the risk of acute lymphoblastic leukemia and B lineage acute lymphoblastic leukemia in Han Chinese children
por: Mei, Endian, et al.
Publicado: (2020) -
Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia
por: Vanden Bempt, Marlies, et al.
Publicado: (2018)